About
royalty pharma is the industry leader in acquiring revenue-producing intellectual property – principally royalty interests in marketed and late stage biopharmaceutical products with $13 billion in assets. since inception in 1996, royalty pharma and its pre
CEOPablo Gerardo Legorreta
HQNew York, New York
Employees92